ScreenerHero

GELS Gelteq Limited

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · gelteq.com
0.5601USD-3.38%Mkt Cap: 6.00M $P/E: —

Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia. It offers edible gels for prescription drugs,…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap6.00M USD
Enterprise Value11.59M USD
Revenue (TTM)471.80K USD
Gross Profit356.40K USD
Net Income (TTM)-6.65M USD
Revenue/Share0.05 USD
Last Price0.5601 USD
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees7
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-2.26
EV/Revenue24.56
P/S13.16
P/B0.66
EPS (TTM)-0.47
EPS (Forward)—
52W Range
0.387011% of range2.010
52W High2.010 USD
52W Low0.3870 USD
Profitability
Gross Margin75.54%
Oper. Margin-1985.28%
EBITDA Margin0.00%
Profit Margin-4011.86%
ROE-42.05%
ROA-30.94%
Growth
Revenue Growth48.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-3.01M USD
CapEx (TTM)642.23K USD
FCF Margin-1007.19%
FCF Yield-79.21%
Net Debt5.10M USD
Net Debt/EBITDA-0.99
Balance Sheet
Debt/Equity0.27
Current Ratio0.09
Quick Ratio0.07
Book Value/Sh0.88 USD
Cash/Share0.0010 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.10.71M
Float5.15M
Insiders47.53%
Institutions1.03%
Short Interest
Short Ratio0.0d
Short % Float3.07%
Short % Out.2.04%
Shares Short218.61K
Short (prev mo.)12.66K
Technical
SMA 500.5962 (-6.0%)
SMA 2000.6965 (-19.6%)
Beta—
S&P 52W Chg16.45%
Avg Vol (30d)5.46M
Avg Vol (10d)3.50M
Technical Indicators
RSI (14)46.8
MACD-0.0223
MACD Signal-0.0199
MACD Hist.-0.0024
BB Upper0.7199 USD
BB Middle0.5869 USD
BB Lower0.4540 USD
BB Width45.31%
ATR (14)0.0815 USD
Vol Ratio (20d)0.05x